228 related articles for article (PubMed ID: 20219977)
1. The positive effects of growth hormone-releasing peptide-6 on weight gain and fat mass accrual depend on the insulin/glucose status.
Granado M; García-Cáceres C; Frago LM; Argente J; Chowen JA
Endocrinology; 2010 May; 151(5):2008-18. PubMed ID: 20219977
[TBL] [Abstract][Full Text] [Related]
2. Insulin and growth hormone-releasing peptide-6 (GHRP-6) have differential beneficial effects on cell turnover in the pituitary, hypothalamus and cerebellum of streptozotocin (STZ)-induced diabetic rats.
Granado M; García-Cáceres C; Tuda M; Frago LM; Chowen JA; Argente J
Mol Cell Endocrinol; 2011 Apr; 337(1-2):101-13. PubMed ID: 21352888
[TBL] [Abstract][Full Text] [Related]
3. Voglibose administration regulates body weight and energy intake in high fat-induced obese mice.
Do HJ; Jin T; Chung JH; Hwang JW; Shin MJ
Biochem Biophys Res Commun; 2014 Jan; 443(3):1110-7. PubMed ID: 24388987
[TBL] [Abstract][Full Text] [Related]
4. Activation of hypothalamic NPY, AgRP, MC4R, AND IL-6 mRNA levels in young Lewis rats with early-life diet-induced obesity.
Stofkova A; Skurlova M; Kiss A; Zelezna B; Zorad S; Jurcovicova J
Endocr Regul; 2009 Jul; 43(3):99-106. PubMed ID: 19817504
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone secretagogues stimulate the hypothalamic-pituitary-adrenal axis and are diabetogenic in the Zucker diabetic fatty rat.
Clark RG; Thomas GB; Mortensen DL; Won WB; Ma YH; Tomlinson EE; Fairhall KM; Robinson IC
Endocrinology; 1997 Oct; 138(10):4316-23. PubMed ID: 9322945
[TBL] [Abstract][Full Text] [Related]
6. GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.
Tschöp M; Statnick MA; Suter TM; Heiman ML
Endocrinology; 2002 Feb; 143(2):558-68. PubMed ID: 11796511
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment with the ghrelin receptor antagonist [d-Lys3]-GHRP-6 does not improve glucose homeostasis in nonobese diabetic MKR mice.
Mosa R; Huang L; Li H; Grist M; LeRoith D; Chen C
Am J Physiol Regul Integr Comp Physiol; 2018 Jan; 314(1):R71-R83. PubMed ID: 28903914
[TBL] [Abstract][Full Text] [Related]
8. Delayed age-associated decrease in growth hormone pulsatile secretion and increased orexigenic peptide expression in the Lou C/JaLL rat.
Kappeler L; Zizzari P; Alliot J; Epelbaum J; Bluet-Pajot MT
Neuroendocrinology; 2004; 80(5):273-83. PubMed ID: 15677878
[TBL] [Abstract][Full Text] [Related]
9. Effects of coadministered growth hormone (GH)-releasing hormone and GH-releasing hexapeptide on maladaptive aspects of obesity in Zucker rats.
Bercu BB; Yang SW; Masuda R; Hu CS; Walker RF
Endocrinology; 1992 Dec; 131(6):2800-4. PubMed ID: 1446617
[TBL] [Abstract][Full Text] [Related]
10. Leptin levels in protracted critical illness: effects of growth hormone-secretagogues and thyrotropin-releasing hormone.
Van den Berghe G; Wouters P; Carlsson L; Baxter RC; Bouillon R; Bowers CY
J Clin Endocrinol Metab; 1998 Sep; 83(9):3062-70. PubMed ID: 9745404
[TBL] [Abstract][Full Text] [Related]
11. Role of ghrelin in streptozotocin-induced diabetic hyperphagia.
Ishii S; Kamegai J; Tamura H; Shimizu T; Sugihara H; Oikawa S
Endocrinology; 2002 Dec; 143(12):4934-7. PubMed ID: 12446621
[TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory effect of the ghrelin agonist growth hormone-releasing peptide-2 (GHRP-2) in arthritic rats.
Granado M; Priego T; Martín AI; Villanúa MA; López-Calderón A
Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E486-92. PubMed ID: 15507538
[TBL] [Abstract][Full Text] [Related]
13. GH responses to GHRH and GHRP-6 in Streptozotocin (STZ)-diabetic rats.
Diz Chaves Y; Spuch Calvar C; Pérez Tilve D; Mallo Ferrer F
Life Sci; 2003 Nov; 73(26):3375-85. PubMed ID: 14572879
[TBL] [Abstract][Full Text] [Related]
14. Plasma and hypothalamic peptide-hormone levels regulating somatotroph function and energy balance in fed and fasted states: a comparative study in four strains of rats.
Kappeler L; Zizzari P; Grouselle D; Epelbaum J; Bluet-Pajot MT
J Neuroendocrinol; 2004 Dec; 16(12):980-8. PubMed ID: 15667453
[TBL] [Abstract][Full Text] [Related]
15. Hypoleptinemia, but not hypoinsulinemia, induces hyperphagia in streptozotocin-induced diabetic rats.
Hidaka S; Yoshimatsu H; Kondou S; Oka K; Tsuruta Y; Sakino H; Itateyama E; Noguchi H; Himeno K; Okamoto K; Teshima Y; Okeda T; Sakata T
J Neurochem; 2001 May; 77(4):993-1000. PubMed ID: 11359864
[TBL] [Abstract][Full Text] [Related]
16. Role of endogenous ghrelin in the hyperphagia of mice with streptozotocin-induced diabetes.
Dong J; Peeters TL; De Smet B; Moechars D; Delporte C; Vanden Berghe P; Coulie B; Tang M; Depoortere I
Endocrinology; 2006 Jun; 147(6):2634-42. PubMed ID: 16484325
[TBL] [Abstract][Full Text] [Related]
17. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin.
Mizuno TM; Makimura H; Silverstein J; Roberts JL; Lopingco T; Mobbs CV
Endocrinology; 1999 Oct; 140(10):4551-7. PubMed ID: 10499510
[TBL] [Abstract][Full Text] [Related]
18. Alcohol intake modifies leptin, adiponectin and resistin serum levels and their mRNA expressions in adipose tissue of rats.
Pravdova E; Macho L; Fickova M
Endocr Regul; 2009 Jul; 43(3):117-25. PubMed ID: 19817506
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing peptide-6 increases insulin-like growth factor-I mRNA levels and activates Akt in RCA-6 cells as a model of neuropeptide Y neurones.
Frago LM; Pañeda C; Argente J; Chowen JA
J Neuroendocrinol; 2005 Nov; 17(11):701-10. PubMed ID: 16218998
[TBL] [Abstract][Full Text] [Related]
20. Hypophysectomy prevents ghrelin-induced adiposity and increases gastric ghrelin secretion in rats.
Tschöp M; Flora DB; Mayer JP; Heiman ML
Obes Res; 2002 Oct; 10(10):991-9. PubMed ID: 12376579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
